PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension

Merabet, Nassiba; Nsaibia, Mohamed Jalloul; Nguyen, Quang Trinh; Shi, Yan Fen; Létourneau, Myriam; Fournier, Alain; Tardif, Jean-Claude; Harel, François et Dupuis, Jocelyn (2019). PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension Scientific Reports , vol. 9 , nº 6609. pp. 1-7. DOI: 10.1038/s41598-019-43225-3.

Prévisualisation

PDF - Version publiée Télécharger (1MB) | Prévisualisation

Résumé

Endothelial dysfunction is a core pathophysiologic process in pulmonary arterial hypertension (PAH). We developed PulmoBind (PB), a novel imaging biomarker of the pulmonary vascular endothelium. (99m)Technetium ((99m)Tc)-labelled PB binds to adrenomedullin receptors (AM1) densely expressed in the endothelium of alveolar capillaries. We evaluated the effect of sildenafil on AM1 receptors activity using (99m)Tc-PB. PAH was induced in rats using the Sugen/hypoxia model and after 3 weeks, animals were allocated to sildenafil (25 or 100 mg/kg/day) for 4 weeks. (99m)Tc-PB uptake kinetics was assessed by single-photon emission computed tomography. PAH caused right ventricular (RV) hypertrophy that was decreased by low and high sildenafil doses. Sildenafil low and high dose also improved RV function measured from the tricuspid annulus plane systolic excursion. Mean integrated pulmonary uptake of (99m)Tc-PB was reduced in PAH (508% . min +/- 37, p < 0.05) compared to controls (630% . min +/- 30), but unchanged by sildenafil at low and high doses. Lung tissue expressions of the AM1 receptor components were reduced in PAH and also unaffected by sildenafil. In experimental angio-proliferative PAH, sildenafil improves RV dysfunction and remodeling, but does not modify pulmonary vascular endothelium dysfunction assessed by the adrenomedullin receptor ligand (99m)Tc-PB.

Type de document:	Article
Mots-clés libres:	Diagnostic markers; Experimental models of disease; Molecular imaging; Preclinical research; Vascular diseases
Centre:	Centre INRS-Institut Armand Frappier
Date de dépôt:	21 nov. 2019 16:33
Dernière modification:	21 nov. 2019 16:33
URI:	https://espace.inrs.ca/id/eprint/8576

Gestion Actions (Identification requise)

Modifier la notice